This early research looked at how vaginal hyaluronic acid ovules were associated with changes in women with symptomatic benign cervical ectopy. Because the study did not include a control group, the results should be viewed as exploratory rather than definitive proof. It is important to note that observational studies cannot prove cause and effect on their own.
Researchers followed 121 women who used the treatment once daily for 14 days. Over three months, the rate of epithelial transformation increased from 61.5 percent at four weeks to 82.9 percent at three months. This change was statistically significant, but the clinical meaning is still being studied.
The study did not report on safety concerns, adverse events, or how well patients tolerated the medication. Additionally, symptom relief was not measured using standardized methods, making it hard to compare results. There is no information on whether the treatment caused any harm or discomfort.
Patients should understand that further randomized controlled trials are needed to confirm clinical effectiveness. It is important to discuss these findings with a healthcare provider before making changes to treatment plans. Current evidence is not enough to recommend this treatment for everyone.